mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |